Acumen Pharmaceuticals, Inc. (ABOS)

Acumen Pharmaceuticals Statistics

Total Valuation

ABOS has a market cap or net worth of $102.97 million. The enterprise value is -$2.24 million.

Market Cap	102.97M
Enterprise Value	-2.24M

Important Dates

The last earnings date was Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ABOS has 60.57 million shares outstanding. The number of shares has increased by 1.58% in one year.

Current Share Class	60.57M
Shares Outstanding	60.57M
Shares Change (YoY)	+1.58%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.92%
Owned by Institutions (%)	29.92%
Float	35.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.10
P/TBV Ratio	1.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.02, with a Debt / Equity ratio of 0.33.

Current Ratio	6.02
Quick Ratio	5.80
Debt / Equity	0.33
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-33.12

Financial Efficiency

Return on equity (ROE) is -85.93% and return on invested capital (ROIC) is -46.55%.

Return on Equity (ROE)	-85.93%
Return on Assets (ROA)	-42.23%
Return on Invested Capital (ROIC)	-46.55%
Return on Capital Employed (ROCE)	-114.94%
Revenue Per Employee	n/a
Profits Per Employee	-$2.19M
Employee Count	61
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.27% in the last 52 weeks. The beta is 0.24, so ABOS's price volatility has been lower than the market average.

Beta (5Y)	0.24
52-Week Price Change	-28.27%
50-Day Moving Average	1.83
200-Day Moving Average	1.38
Relative Strength Index (RSI)	44.17
Average Volume (20 Days)	204,373

Short Selling Information

The latest short interest is 1.37 million, so 2.27% of the outstanding shares have been sold short.

Short Interest	1.37M
Short Previous Month	1.33M
Short % of Shares Out	2.27%
Short % of Float	3.86%
Short Ratio (days to cover)	3.13

Income Statement

Revenue	n/a
Gross Profit	-118.93M
Operating Income	-138.23M
Pretax Income	-133.35M
Net Income	-133.35M
EBITDA	-138.17M
EBIT	-138.23M
Earnings Per Share (EPS)	-$2.21

Balance Sheet

The company has $126.61 million in cash and $30.84 million in debt, giving a net cash position of $105.22 million or $1.74 per share.

Cash & Cash Equivalents	126.61M
Total Debt	30.84M
Net Cash	105.22M
Net Cash Per Share	$1.74
Equity (Book Value)	93.17M
Book Value Per Share	1.55
Working Capital	110.20M

Cash Flow

In the last 12 months, operating cash flow was -$123.66 million and capital expenditures -$88,000, giving a free cash flow of -$123.75 million.

Operating Cash Flow	-123.66M
Capital Expenditures	-88,000
Free Cash Flow	-123.75M
FCF Per Share	-$2.04

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ABOS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.58%
Shareholder Yield	-1.58%
Earnings Yield	-129.50%
FCF Yield	-120.17%

Analyst Forecast

The average price target for ABOS is $7.67, which is 351.18% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.67
Price Target Difference	351.18%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2